Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE
| Errataetall: | |
|---|---|
| Medienart: |
Artikel |
| Erscheinungsjahr: |
2005 |
|---|---|
| Erschienen: |
2005 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
The Annals of pharmacotherapy - 39(2005), 7-8 vom: 11. Juli, Seite 1367 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Siniscalchi, Antonio [VerfasserIn] |
|---|
| Themen: |
44YRR34555 |
|---|
| Anmerkungen: |
Date Completed 26.08.2005 Date Revised 01.12.2018 published: Print-Electronic ErratumIn: Ann Pharmacother. 2005 Sep;39(9):1581 Luca, Gallelli [corrected to Gallelli, Luca]; Ibbadu, Guido Ferreri [corrected to Ferreri, Guido Ibbadu] Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM155966553 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM155966553 | ||
| 003 | DE-627 | ||
| 005 | 20231223073227.0 | ||
| 007 | tu | ||
| 008 | 231223s2005 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0520.xml |
| 035 | |a (DE-627)NLM155966553 | ||
| 035 | |a (NLM)15956229 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Siniscalchi, Antonio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE |
| 264 | 1 | |c 2005 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 26.08.2005 | ||
| 500 | |a Date Revised 01.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Ann Pharmacother. 2005 Sep;39(9):1581 Luca, Gallelli [corrected to Gallelli, Luca]; Ibbadu, Guido Ferreri [corrected to Ferreri, Guido Ibbadu] | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 650 | 7 | |a Levetiracetam |2 NLM | |
| 650 | 7 | |a 44YRR34555 |2 NLM | |
| 650 | 7 | |a Prednisone |2 NLM | |
| 650 | 7 | |a VB0R961HZT |2 NLM | |
| 650 | 7 | |a Piracetam |2 NLM | |
| 650 | 7 | |a ZH516LNZ10 |2 NLM | |
| 700 | 1 | |a Mancuso, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Gallelli, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Luca, Gallelli |e verfasserin |4 aut | |
| 700 | 1 | |a Ferreri, Guido Ibbadu |e verfasserin |4 aut | |
| 700 | 1 | |a Ibbadu, Guido Ferreri |e verfasserin |4 aut | |
| 700 | 1 | |a Giovambattista, De Sarro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Annals of pharmacotherapy |d 1993 |g 39(2005), 7-8 vom: 11. Juli, Seite 1367 |w (DE-627)NLM012749435 |x 1060-0280 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2005 |g number:7-8 |g day:11 |g month:07 |g pages:1367 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2005 |e 7-8 |b 11 |c 07 |h 1367 | ||